[Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
D000368:Aged; D015765:Almitrine; D001794:Blood Pressure / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006935:Hypercapnia / Q000517:prevention & control*; D008173:Lung Diseases, Obstructive / Q000503:physiopathology* / Q000628:therapy; D008875:Middle Aged; D010100:Oxygen / Q000097:blood*; D010102:Oxygen Inhalation Therapy; D010313:Partial Pressure; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000503:physiopathology
D000697:Central Nervous System Stimulants; D010879:Piperazines; D015765:Almitrine; D010100:Oxygen
Einfluss von Almitrin, einem Chemorezeptorenstimulator, auf die nächtliche Hyperkapnie und den pulmonalarteriellen Druck unter O2-Atmung bei chronisch obstruktiver Lungenerkrankung.